drugset / Trial / NCT01706510

Antiplatelet Effects of Ticagrelor Versus Clopidogrel in American Indian Patients

NCT01706510 ↗

RandomizedCrossoverOpen-labelTreatment

Summary

Assess the pharmacodynamic effect of ticagrelor vs. Clopidogrel in American Indian patients with stable coronary artery disease.

Timeline

Start
2012-12
Primary completion
2014-03
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Clopidogrel Small molecule 75 mg —
Subject Ticagrelor Small molecule 90 mg —